Neurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effect

Simple item page
dc.contributor.authorYuluğ, Burak
dc.contributor.buuauthorParlayan, Ebru
dc.contributor.buuauthorBakar, Mustafa
dc.contributor.buuauthorGümüştaş, Oğuzhan Güven
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Radyoloji Anabilim Dalı.tr_TR
dc.contributor.scopusid40262210100tr_TR
dc.contributor.scopusid26643051200tr_TR
dc.contributor.scopusid9237715700tr_TR
dc.date.accessioned2022-03-08T10:52:15Z
dc.date.available2022-03-08T10:52:15Z
dc.date.issued2009
dc.identifier.citationParlayan, E. vd. (2009). "Neurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effect". Journal of Neuropsychiatry and Clinical Neurosciences, 21(3), 348-350.en_US
dc.identifier.endpage350tr_TR
dc.identifier.issn0895-0172
dc.identifier.issue3tr_TR
dc.identifier.pubmed19776323tr_TR
dc.identifier.scopus2-s2.0-70349633251tr_TR
dc.identifier.startpage348tr_TR
dc.identifier.urihttps://doi.org/10.1176/jnp.2009.21.3.348
dc.identifier.urihttps://neuro.psychiatryonline.org/doi/full/10.1176/jnp.2009.21.3.348
dc.identifier.urihttp://hdl.handle.net/11452/24909
dc.identifier.volume21tr_TR
dc.identifier.wos000270098900023
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherAmer Psychiatric Publishingen_US
dc.relation.collaborationSanayitr_TR
dc.relation.journalJournal of Neuropsychiatry and Clinical Neurosciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeurosciences & neurologyen_US
dc.subjectPsychiatryen_US
dc.subject.emtreeCholine esterase inhibitoren_US
dc.subject.emtreeDonepezilen_US
dc.subject.emtreeNeuroprotective agenten_US
dc.subject.emtreeRivastigmineen_US
dc.subject.emtreeUnclassified drugen_US
dc.subject.emtreeAlzheimer diseaseen_US
dc.subject.emtreeCognitionen_US
dc.subject.emtreeComputer assisted tomographyen_US
dc.subject.emtreeDementiaen_US
dc.subject.emtreeEnzyme inhibitionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreeNeuroprotectionen_US
dc.subject.emtreeNuclear magnetic resonance imagingen_US
dc.subject.emtreeNuclear magnetic resonance spectroscopyen_US
dc.subject.emtreePriority journalen_US
dc.subject.meshAgeden_US
dc.subject.meshAspartic aciden_US
dc.subject.meshBrainen_US
dc.subject.meshCognition disordersen_US
dc.subject.meshDementiaen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshIndansen_US
dc.subject.meshMagnetic resonance spectroscopyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshNeuroprotective agentsen_US
dc.subject.meshNeuropsychological testsen_US
dc.subject.meshPhenylcarbamatesen_US
dc.subject.meshPiperidinesen_US
dc.subject.meshPsychiatric status rating scalesen_US
dc.subject.meshTreatment outcomeen_US
dc.subject.scopusCreatine; N Acetylaspartic Acid; Cognitive Dysfunctionen_US
dc.subject.wosClinical neurologyen_US
dc.subject.wosNeurosciencesen_US
dc.subject.wosPsychiatryen_US
dc.titleNeurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effecten_US
dc.typeLetter
dc.wos.quartileQ2en_US
dc.wos.quartileQ3 (Neurosciences)en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
PubMed
Scopus